1. Home
  2. COLL vs LVWR Comparison

COLL vs LVWR Comparison

Compare COLL & LVWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COLL
  • LVWR
  • Stock Information
  • Founded
  • COLL 2002
  • LVWR 2022
  • Country
  • COLL United States
  • LVWR United States
  • Employees
  • COLL N/A
  • LVWR N/A
  • Industry
  • COLL Biotechnology: Pharmaceutical Preparations
  • LVWR
  • Sector
  • COLL Health Care
  • LVWR
  • Exchange
  • COLL Nasdaq
  • LVWR Nasdaq
  • Market Cap
  • COLL 1.1B
  • LVWR 1.2B
  • IPO Year
  • COLL 2015
  • LVWR N/A
  • Fundamental
  • Price
  • COLL $31.09
  • LVWR $5.65
  • Analyst Decision
  • COLL Strong Buy
  • LVWR Hold
  • Analyst Count
  • COLL 6
  • LVWR 1
  • Target Price
  • COLL $42.00
  • LVWR $7.25
  • AVG Volume (30 Days)
  • COLL 439.3K
  • LVWR 28.6K
  • Earning Date
  • COLL 11-07-2024
  • LVWR 02-06-2025
  • Dividend Yield
  • COLL N/A
  • LVWR N/A
  • EPS Growth
  • COLL 757.11
  • LVWR N/A
  • EPS
  • COLL 2.16
  • LVWR N/A
  • Revenue
  • COLL $599,245,000.00
  • LVWR $30,963,000.00
  • Revenue This Year
  • COLL $13.20
  • LVWR $3.44
  • Revenue Next Year
  • COLL $17.63
  • LVWR $136.41
  • P/E Ratio
  • COLL $14.32
  • LVWR N/A
  • Revenue Growth
  • COLL 9.62
  • LVWR N/A
  • 52 Week Low
  • COLL $28.97
  • LVWR $5.05
  • 52 Week High
  • COLL $42.29
  • LVWR $12.04
  • Technical
  • Relative Strength Index (RSI)
  • COLL 48.70
  • LVWR 42.19
  • Support Level
  • COLL $29.67
  • LVWR $5.17
  • Resistance Level
  • COLL $31.10
  • LVWR $5.85
  • Average True Range (ATR)
  • COLL 0.98
  • LVWR 0.34
  • MACD
  • COLL 0.26
  • LVWR -0.02
  • Stochastic Oscillator
  • COLL 69.41
  • LVWR 51.02

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of highly abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

About LVWR LiveWire Group Inc.

LiveWire Group Inc is an all-electric vehicle company. It sells electric vehicles and related parts and accessories and apparel in the United States and certain international markets. The company's segment includes Electric Motorcycles and STACYC. LiveWire generates revenue from the sale of electric motorcycles, Parts, accessories and apparel.

Share on Social Networks: